Actinium Pharmaceuticals, Inc. (ATNM)

Operating Cash Flow (Statement)

-$5.18M

Quarterly · Period ending: · USD

ATNM logo

ATNM Operating Cash Flow (Statement)

Latest reported-$5.18M
ATNM Quarterly Cash from Operations (-$10.03K → -$5.18M)
High-resolution chart · PNG

ATNM operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Actinium Pharmaceuticals, Inc. Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-5,179,000
-5,870,000
-5,289,000
-6,325,000
-5,392,000
-7,574,000
-5,751,000
-11,975,000
-7,972,000
-7,374,000
-7,490,000
-11,125,000
-13,643,000
-15,077,000
-7,778,000
-5,715,000
27,918,000
-5,781,000
-5,052,000
-5,588,000
-4,584,000
-5,642,000
-6,258,000
-4,994,000
-4,511,000
-5,854,000
-5,010,439
-5,598,518
-5,362,883
-5,489,609
-4,286,883
-6,614,009
-4,210,920
-5,459,244
-3,168,523
-5,869,998
-7,139,893
-5,374,932
-4,240,860
-5,570,126
-6,221,782
-4,756,469
-3,964,263
-3,499,260
-5,267,195
-5,813,050
-5,047,368
-4,239,314
-2,571,124
-2,490,948
-1,344,447
-1,620,149
-1,015,482
-2,312,338
-5,197,870
-1,740
-7,094
-6,006
-4,416
-3,514
9,075
-4,120
-5,075
-13,181
31,515
-5,424
-3,148
-5,230
-155
-10,250
-3,024
-4,854
-3,024
-3,062
-4,499
-4,653
-2,840
-3,500
-4,004
-10,030
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.